Is Viking Therapeutics Stock Going to $100? Realistic Analysis
Investors are weighing big potential against real-world risk. This article breaks down VK2735, market dynamics, and w...
Pharmaceuticals
This tag page gathers 4 Pharmaceuticals articles covering stock moves, earnings previews, and dip-buys to help you evaluate pharma equities and manage risk.
30 articlesReasons Lilly Better Stock: 5 Clear Advantages Over SpaceX
Investors face a choice between a pharmaceutical powerhouse with proven earnings and a high-growth space company unde...
Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Novo Nordisk's Wegovy Pill: Is Wall Street Missing Something Behind 3 Million Prescriptions?
A new milestone for obesity treatment arrives as Novo Nordisk's Wegovy Pill hits 3 million prescriptions. This articl...
Reasons Lilly Stock: 5 Key Upsides Investors Should Watch
This deep dive looks at why Lilly stock may be a standout pick for growth-focused investors. From a dominant obesity ...
IShares Pharma ETF vs SPDR's Biotech: Long-Term Buy?
Investors debating IHE vs XBI face a trade-off between stability and growth. This guide breaks down how ishares pharm...
AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Ixj: Pure Pharma Against—A Global Healthcare Bet Today
Two popular ETFs populate the healthcare investing scene: PPH focuses narrowly on drugmakers, while IXJ spans the bro...
Canada India Have Generic Wegovy? Why the U.S. Keeps Lagging
Investors are weighing a potential pricing shift if canada india have generic Wegovy becomes reality, even as the U.S...
Lilly Stock: Next Stop — Can Lilly Stock Reach $2,000?
Investors are watching Lilly stock: next stop as the company leverages obesity and diabetes drugs, while facing risin...